Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125258021 | 12525802 | 1 | I | 20160523 | 20160705 | 20160705 | PER | US-ASTRAZENECA-2016SE56154 | ASTRAZENECA | 0.00 | F | Y | 0.00000 | 20160705 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125258021 | 12525802 | 1 | PS | IRESSA | GEFITINIB | 1 | Oral | U | 206995 | 250 | MG | TABLET | QD | ||||||
125258021 | 12525802 | 2 | SS | IRESSA | GEFITINIB | 1 | Oral | U | 206995 | 250 | MG | TABLET | QD | ||||||
125258021 | 12525802 | 3 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | 0 | ||||||||||||
125258021 | 12525802 | 4 | C | CALCIUM WITH VITAMIN D | CALCIUMVITAMIN D | 1 | 0 | ||||||||||||
125258021 | 12525802 | 5 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | ||||||||||||
125258021 | 12525802 | 6 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125258021 | 12525802 | 1 | Non-small cell lung cancer |
125258021 | 12525802 | 2 | Non-small cell lung cancer |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125258021 | 12525802 | Chest discomfort | |
125258021 | 12525802 | Dyspnoea | |
125258021 | 12525802 | Feeling abnormal | |
125258021 | 12525802 | Rash macular |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125258021 | 12525802 | 1 | 20160505 | 20160522 | 0 | |
125258021 | 12525802 | 2 | 20160523 | 0 |